Supplementary Table S3 from Inflammatory Marker Testing Identifies CD74 Expression in Melanoma Tumor Cells, and Its Expression Associates with Favorable Survival for Stage III Melanoma
Year: 2023
Type: supplementary-materials
Abstract: This file contains adjuvant treatment distribution in validation set (MDACC) in all patients.
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361918724